Existing research has demonstrated that vinculin represents a promising therapeutic target for conditions such as age-related heart failure, impaired angiogenesis due to dysfunctional high-density lipoprotein (dHDL), atherosclerosis, and other diseases66–68. Here, VCL is linked to atherosclerosis.